rs145760682

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_015175.3(NBEAL2):​c.4485-8C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00477 in 1,602,400 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0034 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0049 ( 27 hom. )

Consequence

NBEAL2
NM_015175.3 splice_region, intron

Scores

2
Splicing: ADA: 0.00003062
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: -1.60

Publications

0 publications found
Variant links:
Genes affected
NBEAL2 (HGNC:31928): (neurobeachin like 2) The protein encoded by this gene contains a beige and Chediak-Higashi (BEACH) domain and multiple WD40 domains, and may play a role in megakaryocyte alpha-granule biogenesis. Mutations in this gene are a cause of gray platelet syndrome. [provided by RefSeq, Dec 2011]
NBEAL2 Gene-Disease associations (from GenCC):
  • gray platelet syndrome
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 3-47001271-C-T is Benign according to our data. Variant chr3-47001271-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 435926.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00342 (520/152250) while in subpopulation AMR AF = 0.00595 (91/15300). AF 95% confidence interval is 0.00496. There are 3 homozygotes in GnomAd4. There are 228 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NBEAL2NM_015175.3 linkc.4485-8C>T splice_region_variant, intron_variant Intron 28 of 53 ENST00000450053.8 NP_055990.1 Q6ZNJ1-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NBEAL2ENST00000450053.8 linkc.4485-8C>T splice_region_variant, intron_variant Intron 28 of 53 2 NM_015175.3 ENSP00000415034.2 Q6ZNJ1-1
NBEAL2ENST00000416683.5 linkc.2346-8C>T splice_region_variant, intron_variant Intron 14 of 39 1 ENSP00000410405.1 H0Y764
NBEAL2ENST00000475689.1 linkn.322C>T non_coding_transcript_exon_variant Exon 1 of 3 2
NBEAL2ENST00000651747.1 linkc.4383-8C>T splice_region_variant, intron_variant Intron 27 of 52 ENSP00000499216.1 A0A494C1V1

Frequencies

GnomAD3 genomes
AF:
0.00342
AC:
520
AN:
152132
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00157
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00596
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000754
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00495
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00301
AC:
743
AN:
246782
AF XY:
0.00287
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.00378
Gnomad ASJ exome
AF:
0.00184
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000701
Gnomad NFE exome
AF:
0.00480
Gnomad OTH exome
AF:
0.00367
GnomAD4 exome
AF:
0.00492
AC:
7131
AN:
1450150
Hom.:
27
Cov.:
32
AF XY:
0.00469
AC XY:
3374
AN XY:
719052
show subpopulations
African (AFR)
AF:
0.000844
AC:
28
AN:
33190
American (AMR)
AF:
0.00414
AC:
183
AN:
44236
Ashkenazi Jewish (ASJ)
AF:
0.00166
AC:
43
AN:
25826
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39384
South Asian (SAS)
AF:
0.000174
AC:
15
AN:
85998
European-Finnish (FIN)
AF:
0.000604
AC:
32
AN:
52964
Middle Eastern (MID)
AF:
0.00157
AC:
9
AN:
5742
European-Non Finnish (NFE)
AF:
0.00591
AC:
6520
AN:
1103030
Other (OTH)
AF:
0.00504
AC:
301
AN:
59780
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
424
848
1273
1697
2121
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
260
520
780
1040
1300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00342
AC:
520
AN:
152250
Hom.:
3
Cov.:
33
AF XY:
0.00306
AC XY:
228
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.00156
AC:
65
AN:
41540
American (AMR)
AF:
0.00595
AC:
91
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.000754
AC:
8
AN:
10612
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00495
AC:
337
AN:
68016
Other (OTH)
AF:
0.00568
AC:
12
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
32
64
96
128
160
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00410
Hom.:
2
Bravo
AF:
0.00394
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00529
EpiControl
AF:
0.00516

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 19, 2017
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

NBEAL2-related disorder Benign:1
Jun 07, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Gray platelet syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.36
DANN
Benign
0.42
PhyloP100
-1.6
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
3.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000031
dbscSNV1_RF
Benign
0.096
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145760682; hg19: chr3-47042761; API